NCT03278925View on ClinicalTrials.gov

Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

August 9, 2018

Primary Completion Date

June 16, 2023

Study Completion Date

December 31, 2024

Conditions
Cirrhosis
Interventions
PROCEDURE

Biopsy

Undergo biopsy

PROCEDURE

Biospecimen Collection

Undergo collection of blood samples

PROCEDURE

Computed Tomography

Undergo CT

DRUG

Defined Green Tea Catechin Extract

Given PO

OTHER

Laboratory Biomarker Analysis

Correlative studies

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

OTHER

Pharmacological Study

Correlative studies

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Ultrasound

Undergo ultrasound

Trial Locations (2)

20007

MedStar Georgetown University Hospital, Washington D.C.

00936

University of Puerto Rico, San Juan

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH